Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol

Metabolism: Clinical and Experimental

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Floyd, Z Elizabeth ^a   Wang, Zhong Q ^a   Kilroy, Gail ^a   Cefalu, William T ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME; RESVERATROL; ROSIGLITAZONE; UBIQUITIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; INSULIN RESPONSE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; GENE EXPRESSION; GLUCOSE; INSULIN; MICE; PPAR GAMMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; STILBENES; TRANSCRIPTION, GENETIC;

EID: 44949129961     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.006     Document Type: Article

References (37)

1. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1[alpha]. Cell 127 (2006) 1109-1122
2. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 280-281
3. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 (2004) 771-776
4. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
5. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94 (1997) 4318-4323
6. Medina-Gomez G., Virtue S., Lelliott C., Boiani R., Campbell M., Christodoulides C., et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes 54 (2005) 1706-1716
7. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4 (1999) 597-609
8. Miles P.D., Barak Y., Evans R.M., and Olefsky J.M. Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding. Am J Physiol Endocrinol Metab 284 (2003) E618-E626
9. Miles P.D., Barak Y., He W., Evans R.M., and Olefsky J.M. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 105 (2000) 287-292
10. Rieusset J., Seydoux J., Anghel S.I., Escher P., Michalik L., Soon Tan N., et al. Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action. Mol Endocrinol 18 (2004) 2363-2377
11. Stewart W.C., Baugh Jr. J.E., Floyd Z.E., and Stephens J.M. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem Biophys Res Commun 324 (2004) 355-359
12. Floyd Z.E., and Stephens J.M. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J Biol Chem 277 (2002) 4062-4068
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
14. Waite K.J., Floyd Z.E., Arbour-Reily P., and Stephens J.M. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J Biol Chem 276 (2001) 7062-7068
15. Gomez-Lechon M.J., Ponsoda X., and Castell J.V. A microassay for measuring glycogen in 96-well cultured cells. Anal Biochem 236 (1996) 296-301
16. Hauser S., Adelmant G., Sarraf P., Wright H.M., Mueller E., and Spiegelman B.M. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J Biol Chem 275 (2000) 18527-18533
17. Ge H., Zhang J.F., Guo B.S., He Q., Wang B.Y., He B., et al. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. Vasc Pharmacol 46 (2007) 114-121
18. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., and Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 352 (2003) 203-206
19. Ulrich S., Loitsch S.M., Rau O., von Knethen A., Brune B., Schubert-Zsilavecz M., et al. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 66 (2006) 7348-7354
20. Yan B., Wang H., Kon T., and Li C.Y. Pim-1 kinase inhibits the activation of reporter gene expression in Elk-1 and c-Fos reporting systems but not the endogenous gene expression: an artifact of the reporter gene assay by transient co-transfection. Braz J Med Biol Res 39 (2006) 169-176
21. Chattopadhyay S., Whitehurst C.E., and Chen J. A nuclear matrix attachment region upstream of the T cell receptor beta gene enhancer binds Cux/CDP and SATB1 and modulates enhancer-dependent reporter gene expression but not endogenous gene expression. J Biol Chem 273 (1998) 29838-29846
22. Schoonjans K., Staels B., and Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302 (1996) 93-109
23. Hua X.X., Enerback S., Hudson J., Youkhana K., and Gimble J.M. Cloning and characterization of the promoter of the murine lipoprotein lipase-encoding gene: structural and functional analysis. Gene 107 (1991) 247-258
24. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8 (1994) 1224-1234
25. Devine J.H., Eubank D.W., Clouthier D.E., Tontonoz P., Spiegelman B.M., Hammer R.E., et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem 274 (1999) 13604-13612
26. Tontonoz P., Hu E., Devine J., Beale E.G., and Spiegelman B.M. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15 (1995) 351-357
27. Tordjman J., Chauvet G., Quette J., Beale E.G., Forest C., and Antoine B. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 278 (2003) 18785-18790
28. Brady M.J., Bourbonais F.J., and Saltiel A.R. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells. J Biol Chem 273 (1998) 14063-14066
29. Jensen T.C., Crosson S.M., Kartha P.M., and Brady M.J. Specific desensitization of glycogen synthase activation by insulin in 3T3-L1 adipocytes. Connection between enzymatic activation and subcellular localization. J Biol Chem 275 (2000) 40148-40154
30. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma). J Biol Chem 270 (1995) 12953-12956
31. Gray S.L., Nora E.D., Grosse J., Manieri M., Stoeger T., Medina-Gomez G., et al. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55 (2006) 2669-2677
32. Larsen T.M., Toubro S., and Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?. Int J Obes Relat Metab Disord 27 (2003) 147-161
33. Floyd Z.E., and Stephens J.M. Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. Obes Res 12 (2004) 921-928
34. Koubova J., and Guarente L. How does calorie restriction work?. Genes Dev 17 (2003) 313-321
35. Bluher M., Kahn B.B., and Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299 (2003) 572-574
36. Barzilai N., and Gabriely I. The role of fat depletion in the biological benefits of caloric restriction. J Nutr 131 (2001) 903S-906S
37. Liao W., Nguyen M.T., Yoshizaki T., Favelyukis S., Patsouris D., Imamura T., et al. Suppression of PPARγ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293 (2007) E219-E227